News

COVID-19 Vaccine
Featured Story

FDA grants third COVID-19 vaccine, developed in part at BIDMC, emergency use authorization

The FDA grants Johnson & Johnson’s single-shot COVID-19 vaccine, developed in part at BIDMC, emergency use authorization, which may speed vaccine delivery.

Latest News

Covid-19 Vaccines Yield Breakthroughs in Long-Term Fight Against Infectious Disease
BIDMC in the News Wall Street Journal

Covid-19 Vaccines Yield Breakthroughs in Long-Term Fight Against Infectious Disease

FEB. 28, 2021
FDA Issues Emergency Use Authorization for Johnson & Johnson Vaccine
BIDMC in the News Good Morning America

FDA Issues Emergency Use Authorization for Johnson & Johnson Vaccine

FEB. 28, 2021
FDA grants third COVID-19 vaccine, developed in part at BIDMC, emergency use authorization
Featured Story

FDA grants third COVID-19 vaccine, developed in part at BIDMC, emergency use authorization

FEB. 28, 2021
FDA's Expert Panel Voted in Favor of the Johnson & Johnson Shot
BIDMC in the News New York Times

FDA's Expert Panel Voted in Favor of the Johnson & Johnson Shot

FEB. 26, 2021